Theratechnologies Inc (TSE:TH) – National Bank Financial issued their Q3 2016 earnings estimates for Theratechnologies in a note issued to investors on Wednesday. National Bank Financial analyst E. Leno forecasts that the firm will post earnings per share of $0.01 for the quarter. National Bank Financial also issued estimates for Theratechnologies’ Q4 2016 earnings at $0.01 EPS, FY2016 earnings at $0.01 EPS, FY2017 earnings at ($0.01) EPS and FY2018 earnings at ($0.02) EPS.

A number of other equities analysts have also weighed in on TH. Mackie decreased their target price on Theratechnologies from C$5.30 to C$4.40 in a research note on Wednesday, July 6th. Canaccord Genuity decreased their target price on Theratechnologies from C$4.25 to C$3.75 in a research note on Thursday, July 7th.

Theratechnologies (TSE:TH) opened at 2.89 on Monday. Theratechnologies has a 12 month low of $1.26 and a 12 month high of $3.74. The company has a 50 day moving average price of $2.64 and a 200-day moving average price of $2.46. The company has a market cap of $190.54 million and a PE ratio of 262.73.

About Theratechnologies

Theratechnologies Inc is a Canada-based specialty pharmaceutical company. The Company addresses medical needs in metabolic disorders to promote healthy ageing among human immunodeficiency virus (HIV) patients. The Company’s product, EGRIFTA (tesamorelin for injection), is used for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy.

Receive News & Stock Ratings for Theratechnologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies Inc and related stocks with our FREE daily email newsletter.